|
|
|
1-10 employees
View all
|
|
Medical Devices
|
|
8 pinchas sapir st, Ness Tsiona, israel 6082365, IL
|
|
CardiaCare has developed the world's first wearable therapy for treating Atrial Fibrillation. Despite new therapies, Atrial fibrillation (AFib) is still the most common sustained arrhythmia and is considered a rising epidemic affecting millions of people world wide. CardiaCare technology utilizes noninvasive peripheral neuromodulation to mediate a cardiovascular anti arrhythmic response that reduces atrial fibrillation burden. The technology employs a closed loop approach involving both monitoring and therapy. With expert leadership and enthusiastic investors CardiaCare is now planning it’s first regulatory human clinical trial.
|
CardiaCare Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used CardiaCare email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact CardiaCare customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.